Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

06 févr. 2024 08h10 HE | Source: Gallant Therapeutics

Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors

Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
08 janv. 2024 08h00 HE | Source: Gallant Therapeutics

Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets

Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets
06 déc. 2023 08h19 HE | Source: Gallant Therapeutics

Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis

Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis
03 oct. 2023 08h12 HE | Source: Gallant Therapeutics

Ethos Discovery and Gallant Therapeutics Collaborate on Study Evaluating Gallant’s Stem Cell Therapy in Pugs with Necrotizing Meningoencephalitis (NME), also referred to as Pug Dog Encephalitis (PDE)

Gallant Therapeutics and Ethos Discovery collaborate in a clinical study evaluating the use of stem cells to treat pugs with early-stage NME